GSK241227C36000
- 0.06
- 0.000.00%
GlaxoSmithKline Newsroom
The USA FDA has revoked the emergency use authorization for four COVID-19 antibody drugs.
On December 24, Gelonghui reported that the USA Food and Drug Administration (FDA) has revoked the emergency use authorization for four COVID-19 antibody drugs, including Eli Lilly and Co's bebtelovimab, AstraZeneca's Evusheld, GlaxoSmithKline's sotrovimab, and Regeneron's REGEN-COV. The FDA stated in a letter earlier this month that the shelf life of these drugs has expired, and due to the spread of non-susceptible variants, they have not been authorized for patient use for more than a year. According to the FDA, the four companies mentioned above do not intend to continue providing the relevant products in the USA and will notify customers and suppliers.
Pfizer's Progress on C. Diff Vaccine and Pneumococcal Shot Wins Analyst Conviction
GSK COVID Antiviral Authorization for Sotrovimab Revoked by FDA
GlaxoSmithKline (GSK) Gets a Hold From Barclays
GSK Announced Headline Results From FIRST-ENGOT-OV44 Phase 3 Trial Of Zejula (Niraparib) And Jemperli (Dostarlimab) In First Line Advanced Ovarian Cancer, The Trial Met Its Primary Endpoint Of Progression-free Survival, The Key Secondary Endpoint Of...
GSK's Combination of Cancer Drugs Shows Positive Results in Late-Stage Trial
GSK's Ovarian Cancer Treatment Meets Primary Endpoint in Late-stage Study
Your Healthcare Costs Are Soaring! US Spending Reached $5 Trillion In 2023 With Major Increase in Obesity and Diabetes Drugs, Hospital Services
GlaxoSmithKline (GSK) Gets a Hold From Goldman Sachs
GSK (GSK.US) monoclonal antibody first-line therapy has received FDA breakthrough therapy designation for the treatment of rectal cancer.
The USA FDA has granted Breakthrough Therapy Designation (BTD) to its PD-1 inhibitor Jemperli (dostarlimab) for the treatment of locally advanced mismatch repair-deficient (dMMR)/high microsatellite instability (MSI-H) colorectal cancer.
CA Governor Newsom Proclaimed State Of Emergency To Further Enhance State's Preparedness And Accelerate The Bird Flu Cross-Agency Response Efforts
CDC Confirms First Severe Case Of H5N1 Bird Flu In U.S. On December 13; Patient Hospitalized With Severe Case Of Avian Influenza A Virus Infection In Louisiana
Promising Data for Treating Gastrointestinal Cancer Leading to Hopeful Advancements for Pancreatic & Anal Cancers
Cautious Outlook on GlaxoSmithKline: Sell Rating Due to Pipeline and Financial Challenges
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
GSK Gets CHMP Nod for Expanded Use of HIV Combo & Jemperli
Deutsche Bank Keeps Their Hold Rating on GlaxoSmithKline (GSK)
Express News | The well-known European activist investment firm Bluebell is shutting down its hedge fund.
The Committee For Medicinal Products For Human Use Of The European Medicines Agency Has Recommended Expanding The Approval Of GSK's Jemperli (Dostarlimab) In Combination With Chemotherapy (Carboplatin And Paclitaxel) For First-line Treatment For...
GSK Passes Three Significant Milestones With New Cancer Drug Given a Double Boost | LSE:GSK, NYSE:GSK